Cancer-slaying virus may fight childhood eye tumor

OPACC
Jan 24, 2019
1 min read

Curing the childhood eye cancer retinoblastoma often comes at a cost. The tumor, which sprouts in the retina and primarily occurs in children under the age of 5, is fatal if not treated. Yet chemotherapy can cause permanent vision loss, and patients sometimes need surgery to remove one or both eyes. Now, scientists have found that a cancer-slaying virus seems to combat this cancer in mice without serious side effects.

Comments

Finding the balance between efficacy and toxicity in pediatric cancer treatment

Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug

FDA Grants Rare Pediatric Designation for Iopofosine-131 in Glioma Subset

‘Switch’ could turn off growth of tough childhood cancer

Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing

Higher levels of HIF2α found to slow down aggressive childhood cancer

University of Minnesota study uncovers new genetic factors in childhood leukemia

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Researchers develop a new approach for treating children with neuroblastoma

Pesticides used near farm communities tied to rare but deadly childhood cancer

Recent Posts